Thews, O.* ; Schmid, T.* ; Kluttig, A.* ; Wienke, A.* ; Zinkhan, M.* ; Ahrens, W.* ; Barnighausen, T.* ; Brenner, H.* ; Castell, S.* ; Lange, B.* ; Lieb, W.* ; Greiser, K.H.* ; Dörr, M.* ; Krist, L.* ; Willich, S.N.* ; Harth, V.* ; Obi, N.* ; Leitzmann, M.* ; Peters, A. ; Schmidt, B.* ; Schulze, M.B.* ; Völzke, H.* ; Nauck, M.* ; Zylla, S.* ; Hannemann, A.* ; Pischon, T.* ; Velásquez, I.M.* ; Girndt, M.* ; Grossmann, C.* ; Gekle, M.*
Physiological serum uric acid concentrations correlate with arterial stiffness in a sex-dependent manner.
BMC Med. 23:356 (2025)
BACKGROUND: In humans, uric acid is a product of purine metabolism that impacts the vascular system. In addition to effects on arterial vascular tone, associations between serum uric acid concentrations-even in the physiological range-and arterial hypertension and vascular-mediated end-organ damage due to an impact on vascular stiffness have been postulated. METHODS: Therefore, we aim to investigate a possible cross-sectional association between serum uric acid concentrations in the physiological range and differences in arterial pulse wave velocity (PWV), an indicator of vascular remodeling, with a focus on possible differences between female and male individuals. We analyzed cross-sectional phenotypic and laboratory parameters, including PWV from 70,649 individuals in the population-based German National Cohort (NAKO) in a sex-specific manner. In parallel, we applied a machine learning approach to identify and quantify factors associated with PWV in a hypothesis-free manner. RESULTS: Our analysis uncovered a positive association between serum uric and PWV which was detected even if only individuals with urate values in the physiological range were included (n = 64,095). This correlation was more pronounced in women than in men. In multivariable linear regression models, we observed an association of uric acid (mmol/l) with PWV (m/s) of β = 1.12 (95% confidence interval (CI): 0.78; 1.45) in males and β = 1.35 (1.05; 1.66) in females, independent of other factors known to affect vascular stiffness. In addition, the machine learning approach identified uric acid as a major factor associated with PWV. The positive association was not restricted to hyperuricemia but evident even in the physiological concentration range. Based on the data from studies on the impact of aging on PWV, it is estimated that an increase in serum uric acid concentration by 0.1 mmol/l corresponds to an increase of approx. 7 years of age in females and of 4 years in males. CONCLUSIONS: Already in the physiological concentration range, uric acid is positively associated with parameters of arterial stiffness. This association is more pronounced in females as compared to males. This finding provides a mechanistic explanation for the increased risk of vascular end-organ damage associated with higher serum uric acid concentrations and supports the observed greater benefit of therapeutic uric acid lowering in female. Future intervention studies have to address the mechanistic causality of the observed effect.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Female Health ; Hyperuricemia ; Pulse Wave Velocity ; Urate ; Vascular Damage ; Vascular Stiffness; Chronic Heart-failure; All-cause Mortality; Middle-aged Men; Cardiovascular Mortality; Risk-factor; Molecular-identification; Essential-hypertension; Blood-pressure; Hyperuricemia; Allopurinol
Keywords plus
Language
english
Publication Year
2025
Prepublished in Year
0
HGF-reported in Year
2025
ISSN (print) / ISBN
1741-7015
e-ISSN
1741-7015
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 23,
Issue: 1,
Pages: ,
Article Number: 356
Supplement: ,
Series
Publisher
Bmc
Publishing Place
Campus, 4 Crinan St, London N1 9xw, England
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
Institute(s)
Institute of Epidemiology (EPI)
POF-Topic(s)
30202 - Environmental Health
Research field(s)
Genetics and Epidemiology
PSP Element(s)
G-504000-010
G-504000-007
Grants
Federal states of Germany
Federal Ministry of Education and Research (BMBF)
Copyright
Erfassungsdatum
2025-07-03